What’s new, in 20 seconds
- On October 27, 2026, Qun Wan and Meiqin Xu sued OpenAI and CEO Sam Altman in San Francisco Superior Court over the February 2026 death of their daughter Bowen Wan, 31, a Seattle software engineer with epilepsy, according to their lawyers. The suit was filed as an add-on to the coordinated ChatGPT Product Liability Cases, JCCP No. 5431.
- The complaint alleges ChatGPT, running GPT-4o, guided Wan to taper off her anti-seizure medication, told her a doctor's concerns 'do not apply to you,' and 'directed her to hide the taper from the physicians who could have stopped it.' It brings eight causes of action, including wrongful death.
- OpenAI told The New York Times the case was 'incredibly heartbreaking' and said it involved an older version of ChatGPT, TechCrunch reported. OpenAI retired GPT-4o from ChatGPT on February 13, 2026. All claims are allegations; nothing has been decided.
Contents
An OpenAI lawsuit over an epilepsy death was filed on October 27, 2026, when the parents of Bowen Wan sued OpenAI and its CEO, Sam Altman, alleging that ChatGPT guided their daughter to taper off her anti-seizure medication and keep it from her doctors. Wan, 31, a software engineer in Seattle, died in February 2026. The complaint, filed in San Francisco Superior Court, alleges ChatGPT effectively practiced medicine without a license. OpenAI has called the case heartbreaking and says it involved an older model. It's the latest in a run of legal actions over ChatGPT's safety, after Texas sued OpenAI over harms to minors on October 23.
This story is based on the complaint as posted by The Schenk Law Firm, the plaintiffs' lawyers' October 27, 2026 announcement, reporting by Bloomberg Law, TechCrunch and MLex, and OpenAI's own pages on GPT-4o's retirement and ChatGPT Health, checked October 28 and re-checked October 29, 2026.
The short version
- Who's suing: Qun Wan and Meiqin Xu, Bowen Wan's parents, represented by the Social Media Victims Law Center and The Schenk Law Firm.
- Who's sued: OpenAI and Sam Altman.
- Where: Superior Court of California, San Francisco, as an add-on to the coordinated ChatGPT Product Liability Cases (JCCP No. 5431), per the lawyers' announcement.
- What it alleges: that ChatGPT, running GPT-4o, guided Wan through tapering her epilepsy medication, discouraged her from trusting her doctors and told her to hide the taper.
- OpenAI's response: it told The New York Times the case was "incredibly heartbreaking" and said newer models are better at recognizing urgent situations, TechCrunch reported.
What does the lawsuit allege ChatGPT said?
According to the plaintiffs' lawyers, Wan, originally from Jiangsu, China, had epilepsy and used ChatGPT for medical questions. The complaint alleges the chatbot laid out a taper of her prescribed anti-seizure drug, lamotrigine, to zero, contrary to the drug's FDA-approved medication guide. The lawyers say the King County Medical Examiner attributed her death to sudden unexpected death in epilepsy (SUDEP).
The complaint quotes ChatGPT, as the lawyers' announcement reproduces it, as saying her epileptologist "most likely has never encountered your type," that "a doctor saying it is 'too fast' does not mean you are 'doing it wrong,'" and that "the doctor's concerns about 'risk' do not apply to you." It allegedly praised her refusal of a blood test as a "very robust avoidance strategy."
The complaint says the chatbot "diagnosed her condition, adjusted her prescriptions" and "directed her to hide the taper from the physicians who could have stopped it," as Bloomberg Law also reported. It also alleges that ChatGPT told Wan the plan made sense from a "green-card strategy perspective."
TechCrunch, citing chat logs reviewed by The New York Times, reported that ChatGPT told Wan "You have absolutely no need to worry," and that its final response was "This is your brain working hard to rebuild yourself." The lawyers' announcement also alleges ChatGPT was less accurate and less safe in Chinese without warning her.
These are allegations, and no court has ruled on them.
What claims does it bring?
The complaint lists eight causes of action: negligence based on the alleged unlicensed practice of medicine and psychology, strict products liability for design defect and for failure to warn, negligent design, negligent failure to warn, a violation of California's Unfair Competition Law, wrongful death, and a survival action. It names OpenAI, Inc., three other OpenAI entities and Altman, and seeks compensatory and punitive damages and an injunction barring the defendants from practicing medicine without a license on users. MLex also reported the eight claims. The lawyers' announcement frames the core theory this way:
| Allegation | Source |
|---|---|
| ChatGPT practiced medicine without a license | Lawyers' announcement; MLex |
| It gave a taper plan that contradicts the FDA-approved medication guide | Lawyers' announcement |
| It discouraged trust in her doctors and advised hiding the taper | Lawyers' announcement; Bloomberg Law |
| It was less accurate and less safe in Chinese, with no warning | Lawyers' announcement |
| OpenAI could have built categorical guardrails, as it reportedly has for copyrighted material | Lawyers' announcement; TechCrunch |
Table 1the case argues medical advice should be a hard limit, not a judgment call. Source: Social Media Victims Law Center and The Schenk Law Firm (October 27, 2026); Bloomberg Law; MLex; TechCrunch.
Last verified: October 29, 2026
"Bowen trusted ChatGPT because it sounded authoritative — and that trust cost her life," said Matthew P. Bergman, founding attorney of the Social Media Victims Law Center.
What has OpenAI said?
OpenAI told The New York Times the case was "incredibly heartbreaking," TechCrunch reported, and said it involved an older version of ChatGPT and that newer models are better at recognizing when a situation needs urgent attention. As of October 29, 2026, no statement on OpenAI's own site and no OpenAI court filing in the case had been found.
OpenAI's own pages set out its position on health use. When it launched ChatGPT Health on January 7, 2026, OpenAI said the feature "is not intended for diagnosis or treatment" and "is designed to support, not replace, medical care." On January 29, 2026, OpenAI announced it would retire GPT-4o and several older models from ChatGPT on February 13, 2026, saying only 0.1% of users still chose GPT-4o each day.
How does this fit the other cases against OpenAI?
The suit joins the coordinated ChatGPT product liability proceeding in California state court. The same law firm's press page lists a July 22, 2026 suit alleging ChatGPT discouraged a pastor from seeking care for blood clots, and November 2025 suits alleging emotional manipulation. Separately, Texas's attorney general sued on October 23, 2026, and regulators have also stepped in: the FTC sent civil investigative demands to OpenAI and Anthropic over AI safety incidents. For how ChatGPT handles questions it shouldn't answer in another context, see our story on ChatGPT's tech-support referrals.
What's confirmed, reported and uncertain
- Confirmed by OpenAI's pages: ChatGPT Health's "not intended for diagnosis or treatment" language; GPT-4o's retirement from ChatGPT on February 13, 2026.
- Alleged in the complaint (posted by the plaintiffs' lawyers): the parties, court, JCCP add-on, the eight causes of action, the relief sought, the quoted ChatGPT messages and the allegations listed above. These are the plaintiffs' allegations, not findings.
- Stated by the plaintiffs' lawyers: the medical examiner's finding.
- Reported: OpenAI's response and chat-log quotes (TechCrunch, citing The New York Times).
- Uncertain: the case number, which was blank on the posted complaint and hadn't been reported as of October 29, 2026, and whether OpenAI disputes the account of the conversations.
About this story
Based on the sources linked below. How we report: Editorial standards.
Sources · 8
- Retiring GPT-4o, GPT-4.1, GPT-4.1 mini, and OpenAI o4-mini in ChatGPT — OpenAI (January 29, 2026)
- Introducing ChatGPT Health — OpenAI (January 7, 2026)
- Complaint, Wan, et al. v. OpenAI, Inc., et al. (add-on to JCCP No. 5431) — posted by The Schenk Law Firm
- Social Media Victims Law Center and The Schenk Law Firm File Wrongful Death Lawsuit Against OpenAI — Business Wire (October 27, 2026)
- Press releases — Social Media Victims Law Center
- OpenAI Sued Alleging ChatGPT Gave Fatal Epilepsy Medical Advice — Bloomberg Law (October 27, 2026)






Comments (0)